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Clinical observations and management of a
severe equine herpesvirus type 1 outbreak with
abortion and encephalomyelitis
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Abstract
Latent equine herpesvirus type 1 (EHV-1) infection is common in horse populations worldwide and estimated to
reach a prevalence nearing 90% in some areas. The virus causes acute outbreaks of disease that are characterized
by abortion and sporadic cases of myeloencephalopathy (EHM), both severe threats to equine facilities. Different
strains vary in their abortigenic and neuropathogenic potential and the simultaneous occurrence of EHM and
abortion is rare. In this report, we present clinical observations collected during an EHV-1 outbreak caused by a so-
called “neuropathogenic” EHV-1 G2254/D752 polymerase (Pol) variant, which has become more prevalent in recent
years and is less frequently associated with abortions. In this outbreak with 61 clinically affected horses, 6/7
pregnant mares aborted and 8 horses developed EHM. Three abortions occurred after development of EHM
symptoms. Virus detection was performed by nested PCR targeting gB from nasal swabs (11 positive), blood serum
(6 positive) and peripheral blood mononuclear cells (9 positive) of a total of 42 horses sampled. All 6 fetuses tested
positive for EHV-1 by PCR and 4 by virus isolation. Paired serum neutralization test (SNT) on day 12 and 28 after the
index case showed a significant (≥ 4-fold) increase in twelve horses (n = 42; 28.6%). This outbreak with abortions
and EHM cases on a single equine facility provided a unique opportunity for the documentation of clinical disease
progression as well as diagnostic procedures.
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Background
Equine herpesvirus type 1 (EHV-1) is ubiquitous in
horse populations worldwide. Many horses are latently
infected with EHV-1 and reactivation of the virus can
occur under stress, upon which latently infected carriers
start to shed infectious virus that may spread to in-
contact horses [1,2]. Clinical EHV-1 infection can mani-
fest itself in the form of three different clinical syn-
dromes: respiratory disease, usually mild, in horses
under 2 years of age; abortions, typically in the last
trimester of pregnancy; and equine herpesvirus
myeloencephalopathy (EHM) [1-3]. Different strains vary
in their abortigenic potential [4,5] as well as in
neuropathogenicity [6]. A single nucleotide polymorph-
ism (SNP) in the viral DNA polymerase (Pol) gene
(ORF30) is considered one major marker for the
neuropathogenic potential of EHV-1 strains [7,8]. The
A2254/N752 and G2254/D752 Pol variants apparently differ
in their capability of causing EHM [6,8,9]. A2254/N752
(non-neuropathogenic) viruses are mainly isolated from
cases of abortion and less frequently from horses with
EHM. On the other hand, the G2254/D752 Pol variant
(neuropathogenic) is found predominantly associated
with EHM outbreaks [10,11]. The estimated prevalence
of latent EHV-1 infection varies between 54% and 88%,
depending on the population sampled and the method
of virus detection used [3,12]. In the last decades, the
prevalence of the G2254/D752 EHV-1 genotype in EHV-1
positive horses in the United States has apparently in-
creased from 3.3% in the 1960s to 19.4% at the begin-
ning of this century [13-15]. This may indicate a
selective advantage of the neuropathogenic strain, which
also could increase prevalence of EHM in the future.
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Simultaneous latent infection in lymphoid tissues with
both A2254/N752 and G2254/D752 EHV-1 genotypes was
documented in some studies [12,16,17]. Parallel reactiva-
tion of both genotypes was not addressed in these stud-
ies. In contrast, no dual infection with A2254/N752 and
G2254/D752 EHV-1 was detected in 419 fetal isolates [15].
However, 2 EDTA blood samples of febrile horses tested
positive for both genotypes in another study on one farm
(n = 23; 20 abortion outbreaks, 3 EHM outbreaks) with
EHM cases [14].
Detection of the D752 Pol variant in outbreaks without
EHM cases is rare and occurred in only 5% of the cases in
a retrospective worldwide study [7]. In a 23-year retrospect-
ive analysis, 11% (19/176) of isolates carried the G2254/D752
allele, of which 84% (16/19) were collected from EHM
cases and only 16% (3/19) from respiratory or abortion
cases [14]. A combination of abortions with EHM was
documented in 3 of the sampled farms [14]. In Argentina,
7% (4/54) of the abortion outbreaks were induced by
the G2254/D752 variant, and in 2 of these simultaneous
neurologic disease occurred [18]. Two outbreaks with
abortion and EHM cases caused by the neuropathogenic
strain were recently documented in Croatia with breed-
dependent clinical signs: a high incidence of abortion
(53.1%) was described in Lippizaner mares compared to a
lower incidence (10%) in Quarter horses infected with the
identical virus [6].
Various reports with clinical data are available for out-
breaks either with neurological cases or abortion storms
[19-22]. This case report documents for the first time
the clinical data collected during an EHV-1 outbreak
with an uncommon combination of abortion and EHM
on a single facility in Germany.
Case presentation
This report is an account of an acute outbreak of EHV-1
in a mixed horse operation. Consequently, all clinical deci-
sions and laboratory diagnostic procedures were initiated
during the course of the outbreak. The documented out-
break occurred on an equine riding and breeding facility
in southern Germany in early 2009. The stud includes dif-
ferent areas for sport and breeding horses. Broodmares
and breeding stallions were kept separate from the sports
horses. Breeding stallions were attended by grooms, which
did not enter the broodmare or sport horse facilities as re-
quired for a European Union accredited breeding facility.
In the sports horse section, horses were brought onto the
premise without quarantine prior to entering the facility.
The clinical outbreak started in the broodmare section
and spread rapidly to all other barns, except those for
breeding stallions and adolescent horses. Affected horses
were detected in seven of the eleven barns (Figure 1,
Table 1). Adolescent horses (<2 years of age) were
housed in groups of 20 in barns 9 to 11, where
Figure 1 Schematic presentation of the stud (not in scale). A total of 61 clinically affected (fever, abortion, EHM) horses were recorded. For
distribution of clinical cases in the barns see Table 1.
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individual monitoring of body temperatures was not
possible. In the affected areas, a total of 79 horses were
housed. A stud in close proximity to the affected farm
(50 m distance to broodmare barn 7) had no horses with
fever, abortion or EHM, but no virus testing was
performed. The vaccination status of the on-site animals
was variable: All breeding stallions and broodmares were
vaccinateda in accordance with the manufacturers rec-
ommendations, with boosters in the 5th, 7th and 9th
month of gestation. In barns 1 to 6, only 21 (32%) of the
horses were vaccinated. The group of adolescent horses
(barns 9 to 11) was not vaccinated. We view it as likely
that the poor overall vaccination status contributed to
rapid virus spread on the premise. Another contributing
factor for the severity of the outbreak may be the typical
boarding facility situation that includes frequent horse
traffic on and off the premise, which may have
compromised overall herd immunity.
The index case of the outbreak was an abortion in the
broodmare barn 7. The day of the abortion is referred to
as day 1 of the outbreak. Sixty-one clinical cases (77.2%)
were detected during the outbreak and cases were iden-
tified over a period of 44 days. Onset, type and duration
of clinical signs were documented for all individuals and
are documented in the following sections.
Fever
In 71 horses, housed in barns 1 to 7, body temperatures
were taken twice daily, starting on day 5 after the first
abortion (index case). In the remaining 8 horses of the
stabled population, control of body temperature as a
routine procedure was practically impossible. Fever was
defined as a body temperature of 38.1°C or higher
(≥ 100.6°F).
An increase of body temperature was detected in 55 of
the regularly measured 71 horses (77.5%). Since body
temperature measurements had not started before day 5
of the outbreak, we assume that fever was missed in sev-
eral horses in the beginning. The maximum number of
fever cases/day was documented on day 5 with 11
horses. On day 11, a second peak with 10 new cases was
observed (Figure 2). The mean of the horses’ maximal
body temperatures was 39.1 ± 0.7°C (minimum 38.1°C,
maximum 40.8°C) and a mean duration of 3.2 ± 2.2 days
of fever were recorded (minimum 1 day, maximum 9
days, Figure 3). Seven horses (12.7%) were febrile for
more than 5 days. Only 3 (6.5%) of the 55 horses showed
a second febrile episode. Five horses with fever > 38.7°C
with a duration of 5 to 8 days showed mild lethargy.
Body temperatures of individual horses peaked mainly in
the evening with normal temperature readings in the
morning. Without the twice-daily assessment of body
temperatures, many of the infected horses would have
been missed, as fever was only recorded once in eleven
horses. Without the “index” abortion or the first EHM
cases, spread of the disease could have remained undis-
covered, as most of the horses only having fever and no
other symptoms remained in excellent general condition
and did not develop obvious clinical signs. The regular
recording of rectal temperature can be an effective diag-
nostic tool during an EHV-1 outbreak [11] and seems
especially important when no respiratory signs were
detected like during this outbreak.
Abortion
On day 1, 7 pregnant mares (8 to 11 months of gesta-
tion), including the index case mare, were housed in the
broodmare barn 7. Six of the mares lost their foals
(85.7%), one gave birth to a healthy foal. In four mares,
the time between first fever and abortion ranged from
10 to 15 days (10, 10, 12 and 15 days) with fever dura-
tions of 3, 4, 2 and 4 days, respectively. In two mares
that aborted on day 1 and 11, no fever was detected.
Three of the mares developed EHM (Table 2) and
Table 1 Description of horse populations in the different barns on the stud
Barn No. of horses Affected horses Horse descriptiona Same staff as horses of other barns
1 6 5 SH; VH yes
2 8 6 SH; VH yes
3 12 8 SH; VH yes
4 20 14 SH; VH yes
5 12 10 SH; VH yes
6 10 8 SH; VH yes
7 11 10 BM; 1 foal yes
8 10 0 BS no
9-11 90 1 (?)b AH no
aSH = Sport Horses; VH = Visiting Horses; BM = Brood Mares; BS = Breeding Stallions; AH = Adolescent Horses.
bClinical EHM signs, but no laboratory data available.
The index case was an abortion in barn 7. With the exception of the stallion barn and one questionable EHM case in the adolescent group (barns 9–11), all barns
were affected. All affected barns were situated ≤ 50 meters next each other. The adolescent horses were stabled in barns 9–11, situated 500 to 1000 meters from
the other barns. Horses from barns 1 – 7 used the same training facilities and paddocks.
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abortions occurred 5, 7 and 10 days after the onset of
neurological signs. One mare in the 8th month of preg-
nancy had a premature placental separation (red bag de-
livery). One of the mares was also diagnosed with
dystocia following the incorrect position of the dead foal
and absence of uterine contractions. One EHV-1-posi-
tive foal was delivered alive 19 days before term. How-
ever, due to prematurity and distress at birth, it had to
be euthanized for humane reasons. Four mares retained
the fetal membranes after abortion (66.6%).
EHM
Eight of the 61 clinically affected horses (13.1%) devel-
oped neurological signs, which we all attributed to EHV-
1 infection. Neurological symptoms were graded
according to Reed and Andrews [23]. Fever was detected
before onset of clinical signs of EHM in 3 of the 8 cases.
In 5 horses, EHM symptoms became evident between
day 5 and 9 of the outbreak without a preceding fever
period, which could be the result of the delayed imple-
mentation of regular body temperature measurements.
The incubation period for EHM symptoms in experi-
mental and natural infected horses was previously de-
scribed to range between 6 and 8 days [24]. In this
outbreak EHM symptoms developed 5 (two horses) or 9
(one horse) days after the first fever, and 1, 2 and 4 days
after the last fever (Table 2). As reported previously by
other authors, all horses developing EHM were non-
febrile at the onset of neurologic disease [19].
In three horses, neurological signs were restricted to
mild ataxia of the hind limbs (grade 2). Four other
horses suffered from more severe ataxia and upper
motor neuron (UMN) symptoms as evidenced by an in-
ability to open the urethral sphincter for autonomous
urination (grade 4). One horse became temporarily re-
cumbent (grade 5) [23]. The “UMN bladder” was ob-
served between 2 and 13 days after onset of ataxia (2, 4,
10, 12 and 13 days in grade 4 and 5 horses). The average
age of the eight EHM cases was 7.8 ± 4.5 years with a
range of 4 to 16 years. In other studies, horses under five
years of age had a decreased risk to develop EHM
[19,20,22]. This outbreak included 4 EHM horses (50%)
that were only 4 years old, with 3 of these younger
Figure 2 Number of newly detected clinical cases per day during the outbreak.
Figure 3 Duration of fever (≥38.1°C) in individual animals in
days (n = 55/71).
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Table 2 Clinical and laboratory data in individual horses with EHM (n = 8) and/or abortion (n = 6)
Animal Ox Ja Ro Wo Le Wa Cl Du Ho Da Pu
Age/Gendera 10/F 4/G 4/F 4/G 16/F 10/F 4/F 4/G 5/F 9/F 11/F
Vaccination + - - - + + + - + + +
Day of Onset of Fever/EHM/Abortionb (EHM grade)c −/−/1 -/9/- (2) -/7/-(2) -/7/-(2) -/6/11 (4) 5/10/17 (4) 9/-/19 -/7/-(4) 13/-/23 13/18/28 (4) 20/28/-(5)
Fever Max/Durationd −/− −/− −/− −/− −/− 39.2/2 39.4/3 38.9/3 39.1/4 39.8/4 39.4/8
PCRe D12 −/−/- −/−/- +/−/- −/−/- +/−/- +/−/- +/+/+ +/+/+ −/−/- −/−/- n.a.
SNTf D12/D28 384/192 64/48 32/64 32/128 128/128 48/96 16/128 128/192 48/128 96/128 n.a./96
Fetus Cell Culture/PCRg +/+ +/+ −/+ −/+ +/+ +/+
agender: (F = female; G = gelding).
bgiven is the day of the outbreak.
cEHM grade according to Reed and Andrews (2004).
dHighest measured body temperature and duration of fever.
ePCR results from nasal swabs, serum and PBMC, separated by the dash.
fSNT values for the animals sampled on day 12 and 28 of the outbreak.
gLaboratory results of the fetus samples of the abortion cases (cell culture and PCR).
Animals are titled with name abbreviations. Ox is the index case. (n.a. = not available).
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horses developing grade 2 neurological signs. Just one
horse with grade 4 neurological signs was 4 years old
and the 3 other horses suffering from neurological signs
grade 4 were over 9 years of age. Other authors also
described a more severe clinical presentation in older
horses. It was recently shown that the amount of virus
in biological samples was not systematically related to
the intensity of clinical signs observed [11]. During the
outbreak described here, we too were unable to correlate
virus detection and development of EHM (Table 2).
The 13.1% incidence of EHM observed in this out-
break appears relatively low. A cumulative analysis of re-
cords from the United States showed a 26% incidence of
EHM in 452 EHV-1 infected horses, out of which 29%
required euthanasia [25]. A recent report described a
case fatality rate for EHV-1 of 71.4% (5 out of 7) [11].
The high mortality associated with EHM is at odds with
our observations, where all 8 EHM cases survived and
returned to their former level of activities, regardless of
the severity of the disease. How the low EHM incidence
and mortality were influenced by the implemented hep-
arin treatment or supportive veterinary care remains
speculative. Other reports document factors beside the
neuropathogenicity of the virus (breed, sex, age or vac-
cination) that may contribute to the risk to develop se-
vere EHM after EHV-1 infection and may be also
responsible for the good outcomes in this outbreak
[6,26,27].
Laboratory data
The laboratory results confirmed the clinical diagnosis
“EHV-1 infection” that was based on the typical clinical
course with fever (n = 55), abortions (n = 6) and neuro-
logical deficits (n = 8).
Gross pathology and histopathology were performed
on all abortions. An ORF30 (Pol)-specific polymerase
chain reaction (PCR) was used for detection of viral nu-
cleic acid in fetal lung, liver and fetal membranes. Typ-
ical lesions in spleen and liver, with necrosis and
intranuclear inclusion bodies, were detected in all 6
aborted fetuses. In 4 of the aborted fetuses, cell culture
isolation of the virus was successful and in all 6 fetuses
EHV-1-specific PCR amplification was positive. Sequen-
cing of the amplification product was performed after
digestion with restriction enzyme SalI to identify the
EHV-1 Pol D752 genotype [14].
Due to practical reasons, on day 12 of the outbreak,
nasal swabs, blood and sera were collected from 42
horses, irrespective of the development of clinical symp-
toms in individual horses. Antibody titer determinations
specific for EHV-1 and EHV-4 were done using serum
neutralization tests (SNT) and were repeated on day 28
of the outbreak [28]. A ≥ 4-fold titer increase was
detected in 12 horses for EHV-1 (29%) and 13 horses for
EHV-4 (31%). The highest EHV-1 antibody titer deter-
mined was 1:384 and was measured in the index mare
on day 12. This low percentage of horses with serocon-
version is probably the result of the delayed sampling,
which was initiated only 12 days after the index case
(Figure 4). Serum samples were analyzed in two batches
on different days. Therefore, inter-test variability may
have skewed the results. The rise in EHV-4 titers is likely
due to the high cross-reactivity of antibodies against
these closely related viruses [29]. These results confirm
Figure 4 Changes in EHV-1 and EHV-4 antibody titers of serum samples collected on days 12 and 28 after the index case. A ≥ 4-fold
increase in antibody titer is considered a significant rise. A simultaneous and significant increase of EHV-1 and EHV-4 antibodies was detected in
9 horses.
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earlier reports suggesting SNT results are no reliable
tool to diagnose acute EHV-1 infection, especially when
the first sampling is not performed early in the begin-
ning of disease in individual horses [30]. Virus detection
in swabs, blood and peripheral blood mononuclear cells
(PBMC) was performed by conventional nested PCR
targeting glycoprotein B (gB) [31]. PCR diagnosed 11
EHV-1-positive nasal swabs, 6 positive sera and 9 posi-
tive PBMC samples; in total, 17 horses were positive for
EHV-1 in at least one sample. All samples tested positive
for EHV-1 in 3 horses. EHV-4 was not detectable in any
of the samples. The results of our virological and sero-
logical tests confirmed that PCR of nasal swabs and
PBMC samples should be initiated early in the febrile
phase in suspect EHV-1 cases. Discrimination between
EHV-1 and EHV-4 antibodies could have been achieved
using an ELISA assay based on the C terminus of glyco-
protein G [29]. But PCR and cell culture results from
blood samples, nasal swabs and fetuses confirmed the
clinical suspicion of an acute EHV-1 infection, which, in
our opinion, decreased the importance of a differenti-
ation of the antibody response. Additionally to routine
diagnostic samples, semen samples of 3 infected non-
breeding stallions, housed in the sport horse section,
tested positive for EHV-1 by PCR, but not by virus isola-
tion. Which role, if any, venereal shedding plays in
EHV-1 spread requires further investigation [32].
Disease management
From day 1, quarantine was imposed for broodmare barn 7.
From day 5, different grooms attended separate barns. Fa-
cilities were entered through hygienic barriers in which
personnel had to change clothes. Horse movements were
prohibited and all horses remained indoors. However, new
cases of fever were detected in nearly all barns during the
outbreak. We concluded from this observation that quaran-
tine measures were implemented too late and infection had
already been fully established in all areas of the premise (ex-
cept the breeding stallion part). Separation of horses, which
were suspected to shed virus based on clinical symptoms
such as fever, EHM and/or abortion in the affected barns,
was deemed impossible. Isolation facilities were not avail-
able and barn construction could not be changed fast
enough, so horses were able to maintain nose-to-nose con-
tact. All abortions occurred in the broodmare stall and
aborted fetuses and placentas were submitted to patho-
logical examination and taken with precautions in order
not to contaminate the environment. The facility imposed
on itself a voluntary quarantine and all horse transports on
and off the stud were restricted from day 1.
Treatment
At the beginning of the outbreak, clinically healthy
horses (n = 33) received prophylactic IM application of
an immunostimulant based on inactivated parapoxvirus
ovis (2 mL/horse; IM)c given three times in two-day in-
tervals. However, thirty-one (94%) of the treated horses
developed a fever. Administration of a parapoxvirus ovis
preparation was previously described as a successful
measure to avoid severe clinical consequences of EHV-1
and −4 infection in young horses [33], but seemed to be
not effective in our outbreak.
Horses showing fever as the only symptom received
no other medication as long as they maintained good
general condition and appetite. Three horses with fever
were depressed and received flunixin-meglumined
(1.1 mg/kg once daily for 1 – 3 days; IV). Mares that
had an abortion also received flunixin-meglumined and
were treated with heparinb for laminitis prevention,
benzathine-penicilline (10,000 I.U./kg every other day,
three times; IM), gentamicinf (4 mg/kg twice daily for 5
days; IV), oxytocing (15 I.U. as necessary; SC) and uter-
ine lavage treatments.
In an attempt to prevent EHM, heparinb (25.000 I.U.)
was given twice daily for 3 days to 31 febrile horses from
day 10 of the outbreak, while the first 30 horses
exhibiting fever did not receive heparin. Horses showing
signs of EHM were treated symptomatically [34]. The
management was directed towards supportive nursing,
nutritional care and reduction of CNS inflammation
with non-steroidal anti-inflammatory drugs (flunixin-
meglumined,1.1 mg/kg once daily; IV). Generally, EHM
horses showed good appetite but had to be fed at head
level because uptake of food and water from the ground
seemed to be difficult. EHM horses were also treated
with flunixin-meglumined, lactated Ringer solution and
5% glucose solution, depending on the horse’s general
condition and laboratory results. Patients with UMN
bladder were catheterized periodically as was deemed
necessary. A combination of sulfamerazin/trimethoprimh
(45 mg/kg twice daily; PO) was administered for cystitis
prevention until paralysis was resolved.
Disease Outcome
Horses with fever as the sole clinical sign remained in
good general condition over the course of the outbreak
and recovered without complication. Fertility of the
aborting mares was good, as only 1 of the 6 aborting
mares was barren in the following breeding season. All 8
EHM horses survived, ataxia and UMN bladder symp-
toms improved steadily and was resolved completely in
all horses 3 months after infection.
Conclusions
We document a clinical outbreak of EHV-1 caused by a
G2254/D752 ORF30 variant virus resulting in 61 clinical
cases. Infection caused fever (n = 55), abortion (n = 6)
and/or EHM (n = 8) for 44 days in 7 barns. Strict
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containment procedures employed from day 5 of the
outbreak did not prevent spread of virus on the premise.
Abortion (n = 6) and EHM (n = 8) cases provided a
unique opportunity to collect clinical data about disease
progression and prognosis for recovery and fertility. Pro-
cedures to prevent EHV-1 outbreaks include in particu-
lar proper vaccination for newly introduced horses and
the restriction of contact between brood mares, adoles-
cent horses and sport horses with foreign contact
[3,6,27].
Consent
Written informed consent was obtained from the patients
for publication of this report and any accompanying
images.
Endnotes
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